Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23796922 | 1.00 | PTGS2 (0.33) | PTGS2IDO1 | |
| SCHEMBL12362845 | 0.83 | PTGS2 (0.35) | PTGS2 | |
| SCHEMBL19785654 | 0.83 | PTGS2 (0.36) | PTGS2 | |
| SCHEMBL1841062 | 0.80 | TP53 (0.41) | PTGS2IDO1 | |
| SCHEMBL1841064 | 0.80 | TP53 (0.41) | PTGS2IDO1 | |
| SCHEMBL24188622 | 0.79 | TAAR1 (0.39) | IDO1 | |
| SCHEMBL23796904 | 0.78 | MEN1 (0.37) | IDO1 | |
| SCHEMBL23796902 | 0.78 | MEN1 (0.37) | IDO1 | |
| SCHEMBL23796535 | 0.76 | IDO1 (0.38) | PTGS2IDO1 | |
| SCHEMBL23796537 | 0.76 | IDO1 (0.38) | PTGS2IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12312301-B2 | Organosulfur compounds | MARIPOSA THERAPEUTICS LTD. (GB) | 2025-05-27 | — | — | US | disclosed |
| US-20220009882-A1 | ORGANOSULFUR COMPOUNDS | MARIPOSA THERAPEUTICS LTD. (GB) | 2022-01-13 | — | — | US | disclosed |
| EP-3877362-A1 | ORGANOSULFUR COMPOUNDS | Mariposa Therapeutics Ltd. (GB) | 2021-09-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220009882-A1 | ORGANOSULFUR COMPOUNDS | F3, F2, TST | PTGS2 121/4885IDO1 2059/4885 |
| US-12312301-B2 | Organosulfur compounds | TST, MPST, F2 | PTGS2 78/4885IDO1 1452/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.